Related Posts

The price-gouging “pharma bro” is backing out of his promise to lower the cost of Daraprim after jacking up its price by more than 5,000 percent. Martin Shkreli, chief executive officer of Turing Pharmaceuticals AG, became known as ...

Martin Shkreli, a pharmaceutical executive who gained notoriety for jacking up the price of a lifesaving medication, has pleaded not guilty to new charges in his unrelated securities fraud case. Shkreli, 33, appeared Monday in feder...

Martin Shkreli, the reviled hedge fund manager who earned the nickname “Pharma Bro” for buying the rights to a lifesaving drug, jacking up the price 5455 percent, and being unabashedly cavalier about it, has been subpoenaed by Congr...

Embattled former pharma CEO Martin Shkreli didn't win any fans when he raised the price of a lifesaving drug by 5000 percent. But when he was arrested last week, it was for securities fraud, not for his unabashed disregard for human...